This special issue of SCVA focuses on fundamentals and clinical applications of cardiopulmonary bypass in 2014. Today's cardiac anesthesiologists and trainees are continually challenged to stay informed on the many recent advances in cardiac surgery and cardiac anesthetic management. Our goal for this themed issue is to address this challenge through broad-based clinically relevant reviews written by experts in the field. These reviews provide cutting-edge concepts in cardiac anesthesia, as well as historic perspective, fundamentals, and clinical applications of cardiopulmonary bypass.
Our lead article by Dr Hessel, "A Brief History of Cardiopulmonary Bypass," 1 provides an excellent, indepth overview of the development and application of cardiopulmonary bypass. He discusses the great improvements in cardiopulmonary bypass since its inception more than half a century ago. As Dr Hessel rightfully points out, the evolution of cardiopulmonary bypass has not been driven by empirical evidence. Rather, cardiac anesthesiologists and the team caring for cardiac surgery patients have continued to improve techniques through their experience in clinical practice and investigate new modalities in cardiopulmonary bypass. Drs Bechtel and Huffmyer provide an excellent reference for trainees and clinicians in "Anesthetic Management for Cardiopulmonary Bypass: Update for 2014." 2 They focus on the details of anesthetic management in the prebypass period, commencement of cardiopulmonary bypass, and the cardiopulmonary bypass period, as well as separation from cardiopulmonary bypass, and the postbypass period. Furthermore, the article visits potential events that may surround the process of cardiopulmonary bypass, the use of anesthetics and cardiovascular medications, and the requirements of safe, quality anesthetic care of patients undergoing cardiac surgery with cardiopulmonary bypass. In "Perioperative Maintenance of Tissue Perfusion and Cardiac Output in Cardiac Surgery Patients," 3 Drs Lighthall and Singh give a detailed review of determinants, restoration, and optimization of tissue perfusion as they relate to cardiac surgery and intensive care. Finally, "Aortic Surgery and Deep Hypothermic Circulatory Arrest: Anesthetic Update" 4 provides an excellent targeted approach to managing anesthesia in patients presenting for complex aortic arch surgery. In this review, Dr Reed and her colleagues discuss evidencebased outcomes with respect to temperature management, perfusion strategies, hemodynamic goals, adjunct agents, and neuromonitoring.
Shann and Melnitchouk have written a concise review of recent advances in cardiopulmonary bypass circuitry, cannula, and techniques that played a prominent role in the development of minimally or less invasive cardiac surgery. This article-"Advances in Perfusion Techniques: Minimally Invasive Procedures" 5 -also provides an excellent summary of the fundamental underpinnings of strategies and management techniques for the safe practice of minimally invasive cardiac surgery.
Dr McRobb and his group discuss "Recent Advances in Pediatric Cardiopulmonary Bypass," 6 including development of the pediatric oxygenator with low prime volumes and surface areas, integrated arterial filters, and miniature ultrafiltration devices. These advances can result in a significant decrease in cardiopulmonary bypass circuit surface areas and prime volumes, with attenuation of cardiopulmonary bypass-associated hemodilution, and a decrease in the need for homologous red blood cell transfusion. The authors conclude with a detailed summary of techniques of effective pediatric myocardial protection and modified ultrafiltration.
Seminars in Cardiothoracic and Vascular Anesthesia 18(2)
The next 3 articles focus on the pathophysiology, coagulation management, and challenges associated with cardiopulmonary bypass. In "Pathophysiology of Cardiopulmonary Bypass-Current Strategies for the Prevention and Treatment of Anemia, Coagulopathy, and Organ Dysfunction," 7 Dr Esper and his coauthors discuss comorbidities that challenge cardiac anesthesiologists who care for aging cardiac surgery patients. These include anemia, decreased cardiopulmonary reserve, use of antithrombotic therapy, neurocognitive dysfunction, and renal insufficiency. At the end of this review, the authors offer preventive strategies for cardiopulmonary bypass-associated hemodilutional anemia, coagulopathy, inflammation, metabolic derangement, and neurocognitive and renal dysfunction.
Coagulopathy is an expected consequence of cardiopulmonary bypass procedures and can be a serious challenge that may result in massive bleeding requiring transfusion of both blood and coagulation factors. Blood product transfusion is, in turn, independently associated with increased hospital length-of-stay, resource utilization, morbidity, and mortality. In "2014 Update on Coagulation Management for Cardiopulmonary Bypass," 8 Drs Thiele and Raphael discuss aspects of cardiopulmonary bypass-induced coagulopathy with emphasis on intraoperative coagulation testing and the use of transfusion algorithms in patients who develop excessive bleeding after cardiac surgery.
Critical unanticipated events during cardiopulmonary bypass can challenge the most experienced perfusionist, anesthesiologist, and surgeon and can potentially lead to devastating outcomes. Such events may arise from an underlying preexisting condition, problems related to the surgery, or conduct of cardiopulmonary bypass. Dr Mukherji and colleagues describe these events in "Overcoming Challenges in the Management of Critical Events During Cardiopulmonary Bypass," 9 and recommend management strategies derived from current evidence or expert opinion.
The last 2 articles are reviews of literature on diastolic dysfunction as it relates to the perioperative management of patients undergoing cardiac surgery. In "New Insights Into Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction," 10 Dr Gelzinis focuses on the definition, symptoms, and diagnosis of diastolic heart failure and the perioperative management of patients with diastolic heart failure. The timing of this review is highly relevant. Because our cardiac surgery patients are older, and they often have a more severe form of diastolic dysfunction, the perioperative management of these patients can pose unique challenges. Diastolic dysfunction has only recently been linked to increased perioperative morbidity and mortality; however, intraoperative assessment has been difficult. In the last decade, transesophageal echocardiography has emerged as an invaluable tool for performing the complex measurements required to assess diastolic dysfunction intraoperatively. Dr Nicoara and her colleagues have written an excellent review on this topic in "Perioperative Diastolic Dysfunction: A Comprehensive Approach to Assessment by Transesophageal Echocardiography." 11 As a result of the evolution of cardiopulmonary bypass techniques, the incidence of morbidity and mortality has become minimal in cardiac surgery patients. However, as discussed in the following pages, preexisting organ dysfunction, assessment and maintenance of adequate end organ tissue perfusion, complex aortic surgery, coagulopathy, and various cardiopulmonary bypass-related critical events may pose significant challenges to a team of perfusionists, surgeons, and anesthesiologists. Therefore, continued improvements in cardiopulmonary bypass systems, surgical techniques, and therapeutic modalities are expected to minimize the risk for these critical events and further reduce morbidity and mortality in these patients. It is our hope that this compilation of review articles on state-of-the-art advances will help guide trainees and clinicians in the clinical management of patients undergoing cardiac surgery with cardiopulmonary bypass.
